BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35962472)

  • 1. The mitochondrial enzyme FAHD1 regulates complex II activity in breast cancer cells and is indispensable for basal BT-20 cells in vitro.
    Holzknecht M; Guerrero-Navarro L; Petit M; Albertini E; Damisch E; Simonini A; Schmitt F; Parson W; Fiegl H; Weiss A; Jansen-Duerr P
    FEBS Lett; 2022 Nov; 596(21):2781-2794. PubMed ID: 35962472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of human fumarylacetoacetate hydrolase domain-containing protein 1 (FAHD1) as a novel mitochondrial acylpyruvase.
    Pircher H; Straganz GD; Ehehalt D; Morrow G; Tanguay RM; Jansen-Dürr P
    J Biol Chem; 2011 Oct; 286(42):36500-8. PubMed ID: 21878618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial enzyme FAHD1 reduces ROS in osteosarcoma.
    Heberle A; Cappuccio E; Andric A; Kuen T; Simonini A; Weiss AKH
    Sci Rep; 2024 Apr; 14(1):9231. PubMed ID: 38649439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of Fumarylacetoacetate Hydrolase Domain Containing Protein 1 (FAHD1).
    Weiss AKH; Wurzer R; Klapec P; Eder MP; Loeffler JR; von Grafenstein S; Monteleone S; Liedl KR; Jansen-Dürr P; Gstach H
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443596
    [No Abstract]   [Full Text] [Related]  

  • 5. Oxaloacetate decarboxylase FAHD1 - a new regulator of mitochondrial function and senescence.
    Etemad S; Petit M; Weiss AKH; Schrattenholz A; Baraldo G; Jansen-Dürr P
    Mech Ageing Dev; 2019 Jan; 177():22-29. PubMed ID: 30055189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for the bi-functionality of human oxaloacetate decarboxylase FAHD1.
    Weiss AKH; Naschberger A; Loeffler JR; Gstach H; Bowler MW; Holzknecht M; Cappuccio E; Pittl A; Etemad S; Dunzendorfer-Matt T; Scheffzek K; Liedl KR; Jansen-Dürr P
    Biochem J; 2018 Nov; 475(22):3561-3576. PubMed ID: 30348641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and functional comparison of fumarylacetoacetate domain containing protein 1 in human and mouse.
    Weiss AKH; Naschberger A; Cappuccio E; Metzger C; Mottes L; Holzknecht M; von Velsen J; Bowler MW; Rupp B; Jansen-Dürr P
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32068790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depletion of oxaloacetate decarboxylase FAHD1 inhibits mitochondrial electron transport and induces cellular senescence in human endothelial cells.
    Petit M; Koziel R; Etemad S; Pircher H; Jansen-Dürr P
    Exp Gerontol; 2017 Jun; 92():7-12. PubMed ID: 28286170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition.
    Lampa M; Arlt H; He T; Ospina B; Reeves J; Zhang B; Murtie J; Deng G; Barberis C; Hoffmann D; Cheng H; Pollard J; Winter C; Richon V; Garcia-Escheverria C; Adrian F; Wiederschain D; Srinivasan L
    PLoS One; 2017; 12(9):e0185092. PubMed ID: 28950000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of FAH domain-containing protein 1 (FAHD1) as oxaloacetate decarboxylase.
    Pircher H; von Grafenstein S; Diener T; Metzger C; Albertini E; Taferner A; Unterluggauer H; Kramer C; Liedl KR; Jansen-Dürr P
    J Biol Chem; 2015 Mar; 290(11):6755-62. PubMed ID: 25575590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Glycolytic Activity Enhances Stem Cell Reprogramming of Fahd1-KO Mouse Embryonic Fibroblasts.
    Salti A; Etemad S; Cubero MS; Albertini E; Kovacs-Szalka B; Holzknecht M; Cappuccio E; Cavinato M; Edenhofer F; Jansen Dürr P
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of glutamine deprivation on oxidative stress and cell survival in breast cell lines.
    Gwangwa MV; Joubert AM; Visagie MH
    Biol Res; 2019 Mar; 52(1):15. PubMed ID: 30917872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting glutaminase-mediated glutamine dependence in papillary thyroid cancer.
    Yu Y; Yu X; Fan C; Wang H; Wang R; Feng C; Guan H
    J Mol Med (Berl); 2018 Aug; 96(8):777-790. PubMed ID: 29942976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on the value of mitochondrial associated protein fumarylacetoacetate domain containing protein 1 and growth differentiation factor-15 in the diagnosis of sepsis: test results from the patients of a multicenter study].
    Li M; Ren R; Chen S; Chen C; Yan J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Feb; 33(2):180-185. PubMed ID: 33729137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [
    Zhou R; Pantel AR; Li S; Lieberman BP; Ploessl K; Choi H; Blankemeyer E; Lee H; Kung HF; Mach RH; Mankoff DA
    Cancer Res; 2017 Mar; 77(6):1476-1484. PubMed ID: 28202527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyruvate anaplerosis is a mechanism of resistance to pharmacological glutaminase inhibition in triple-receptor negative breast cancer.
    Singleton DC; Dechaume AL; Murray PM; Katt WP; Baguley BC; Leung EY
    BMC Cancer; 2020 May; 20(1):470. PubMed ID: 32450839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual inhibition of glutaminase and carnitine palmitoyltransferase decreases growth and migration of glutaminase inhibition-resistant triple-negative breast cancer cells.
    Reis LMD; Adamoski D; Ornitz Oliveira Souza R; Rodrigues Ascenção CF; Sousa de Oliveira KR; Corrêa-da-Silva F; Malta de Sá Patroni F; Meira Dias M; Consonni SR; Mendes de Moraes-Vieira PM; Silber AM; Dias SMG
    J Biol Chem; 2019 Jun; 294(24):9342-9357. PubMed ID: 31040181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer.
    Grinde MT; Hilmarsdottir B; Tunset HM; Henriksen IM; Kim J; Haugen MH; Rye MB; Mælandsmo GM; Moestue SA
    Breast Cancer Res; 2019 May; 21(1):61. PubMed ID: 31088535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver-Type Glutaminase GLS2 Is a Druggable Metabolic Node in Luminal-Subtype Breast Cancer.
    Lukey MJ; Cluntun AA; Katt WP; Lin MJ; Druso JE; Ramachandran S; Erickson JW; Le HH; Wang ZE; Blank B; Greene KS; Cerione RA
    Cell Rep; 2019 Oct; 29(1):76-88.e7. PubMed ID: 31577957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fumarylacetoacetate hydrolase (FAH) superfamily of enzymes: multifunctional enzymes from microbes to mitochondria.
    Weiss AKH; Loeffler JR; Liedl KR; Gstach H; Jansen-Dürr P
    Biochem Soc Trans; 2018 Apr; 46(2):295-309. PubMed ID: 29487229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.